Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded
- Contract number
- SPE2DB26FWVYD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,747
Award facts
- Contract value 100% obligated
- $1,746.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, valued at $1,746.58. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is set to be completed by November 13, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis and bone-related conditions in military and veteran populations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs globally. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen maintains a robust portfolio of federal contracts and has demonstrated consistent capability to meet the Defense Logistics Agency's pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FWVYD?
SPE2DB26FWVYD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FWVYD worth?
The government has obligated $1,747 on SPE2DB26FWVYD.
Is contract SPE2DB26FWVYD an order under another contract?
Yes. SPE2DB26FWVYD is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB26FWVYD competed?
The extent of competition for SPE2DB26FWVYD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award